Literature DB >> 21399936

A potential role for creatine in drug abuse?

Kristen E D'Anci1, Patricia J Allen, Robin B Kanarek.   

Abstract

Supplemental creatine has been promoted for its positive health effects and is best known for its use by athletes to increase muscle mass. In addition to its role in physical performance, creatine supplementation has protective effects on the brain in models of neuronal damage and also alters mood state and cognitive performance. Creatine is found in high protein foods, such as fish or meat, and is also produced endogenously from the biosynthesis of arginine, glycine, and methionine. Changes in brain creatine levels, as measured using magnetic resonance spectroscopy, are seen in individuals exposed to drugs of abuse and depressed individuals. These changes in brain creatine indicate that energy metabolism differs in these populations relative to healthy individuals. Recent work shows that creatine supplementation has the ability to function in a manner similar to antidepressant drugs and can offset negative consequences of stress. These observations are important in relation to addictive behaviors as addiction is influenced by psychological factors such as psychosocial stress and depression. The significance of altered brain levels of creatine in drug-exposed individuals and the role of creatine supplementation in models of drug abuse have yet to be explored and represent gaps in the current understanding of brain energetics and addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21399936     DOI: 10.1007/s12035-011-8176-2

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  69 in total

1.  1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence.

Authors:  W Adriani; R Canese; F Podo; G Laviola
Journal:  Neurotoxicol Teratol       Date:  2006-12-06       Impact factor: 3.763

2.  Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.

Authors:  A Bender; W Koch; M Elstner; Y Schombacher; J Bender; M Moeschl; F Gekeler; B Müller-Myhsok; T Gasser; K Tatsch; T Klopstock
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

3.  Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease.

Authors:  Jinho Kim; Daniel J Amante; Jennifer P Moody; Christina K Edgerly; Olivia L Bordiuk; Karen Smith; Samantha A Matson; Wayne R Matson; Clemens R Scherzer; H Diana Rosas; Steven M Hersch; Robert J Ferrante
Journal:  Biochim Biophys Acta       Date:  2010-05-09

4.  Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats.

Authors:  Brian D Roy; Jacqueline M Bourgeois; Douglas J Mahoney; Mark A Tarnopolsky
Journal:  Can J Physiol Pharmacol       Date:  2002-10       Impact factor: 2.273

5.  Creatine supplementation lowers brain glutamate levels in Huntington's disease.

Authors:  Andreas Bender; Dorothee P Auer; Thomas Merl; Ralf Reilmann; Phillip Saemann; Alexander Yassouridis; Julia Bender; Adolf Weindl; Matthias Dose; Thomas Gasser; Thomas Klopstock
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

6.  Lower glutamate levels in rostral anterior cingulate of chronic cocaine users - A (1)H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy.

Authors:  Shaolin Yang; Betty Jo Salmeron; Thomas J Ross; Zheng-Xiong Xi; Elliot A Stein; Yihong Yang
Journal:  Psychiatry Res       Date:  2009-11-10       Impact factor: 3.222

7.  Brain metabolic alterations in medication-free patients with bipolar disorder.

Authors:  Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2004-05

8.  Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood.

Authors:  F Niklasson; H Agren
Journal:  Biol Psychiatry       Date:  1984-08       Impact factor: 13.382

Review 9.  Exploring the therapeutic role of creatine supplementation.

Authors:  Bruno Gualano; Guilherme Giannini Artioli; Jacques R Poortmans; Antonio Herbert Lancha Junior
Journal:  Amino Acids       Date:  2009-03-01       Impact factor: 3.520

10.  Prevention of traumatic headache, dizziness and fatigue with creatine administration. A pilot study.

Authors:  George Sakellaris; George Nasis; Maria Kotsiou; Maria Tamiolaki; Giorgos Charissis; Athanasios Evangeliou
Journal:  Acta Paediatr       Date:  2007-12-03       Impact factor: 2.299

View more
  4 in total

1.  Creatine supplementation with specific view to exercise/sports performance: an update.

Authors:  Robert Cooper; Fernando Naclerio; Judith Allgrove; Alfonso Jimenez
Journal:  J Int Soc Sports Nutr       Date:  2012-07-20       Impact factor: 5.150

Review 2.  International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine.

Authors:  Richard B Kreider; Douglas S Kalman; Jose Antonio; Tim N Ziegenfuss; Robert Wildman; Rick Collins; Darren G Candow; Susan M Kleiner; Anthony L Almada; Hector L Lopez
Journal:  J Int Soc Sports Nutr       Date:  2017-06-13       Impact factor: 5.150

3.  Creatine in Health and Disease.

Authors:  Richard B Kreider; Jeffery R Stout
Journal:  Nutrients       Date:  2021-01-29       Impact factor: 5.717

Review 4.  Role of Creatine Supplementation in Conditions Involving Mitochondrial Dysfunction: A Narrative Review.

Authors:  Robert Percy Marshall; Jan-Niklas Droste; Jürgen Giessing; Richard B Kreider
Journal:  Nutrients       Date:  2022-01-26       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.